AI Agent Injects Gene Therapy into Live Mouse Brain in Biotech Startup Experiment

A biotech startup has demonstrated a startling milestone in automated research: an AI agent designed and successfully injected a gene therapy into a live mouse’s brain. The experiment, which the company has not yet named publicly in the source, involved the AI selecting a specific genetic treatment and performing the delicate intracranial injection without human intervention. This breakthrough suggests that machine learning systems could soon handle complex, high-precision laboratory procedures that currently require years of specialized training. The successful injection into a living animal’s brain is particularly significant because it combines decision-making about molecular biology with real-world physical execution—a challenge that has long limited lab automation. If such AI agents become reliable, they could accelerate drug discovery, reduce human error, and lower the cost of preclinical research. However, the development also raises questions about oversight, safety, and the pace at which autonomous systems are entering sensitive biomedical fields. For now, this proof-of-concept offers a glimpse of a future where AI not only analyzes data but also acts on it in living organisms.